50% OFF
MarketBeat All Access
Get 30 days free. Save 50% your first year.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
×
S&P 500   3,693.23
DOW   29,590.41
QQQ   275.51
Get 1TB of Top-Rated Cloud Storage for Life for Just $112
Cash Holders STILL Aren’t Taking Steps to Prepare (Ad)pixel
Saudi Arabia's triumphant week reclaims the West's embrace
Poverty, inflation, fear: Egypt's economy pushed to brink
Sell every Stock except ONE (Ad)
Labour conference starts with focus on 'immoral' tax cuts
German leader continues Gulf tour with stops in UAE, Qatar
Sell every Stock except ONE (Ad)
Germany secures more gas shipments as Scholz visits Gulf
Poverty and inflation: Egypt's economy hit by global turmoil
S&P 500   3,693.23
DOW   29,590.41
QQQ   275.51
Get 1TB of Top-Rated Cloud Storage for Life for Just $112
Cash Holders STILL Aren’t Taking Steps to Prepare (Ad)pixel
Saudi Arabia's triumphant week reclaims the West's embrace
Poverty, inflation, fear: Egypt's economy pushed to brink
Sell every Stock except ONE (Ad)
Labour conference starts with focus on 'immoral' tax cuts
German leader continues Gulf tour with stops in UAE, Qatar
Sell every Stock except ONE (Ad)
Germany secures more gas shipments as Scholz visits Gulf
Poverty and inflation: Egypt's economy hit by global turmoil
S&P 500   3,693.23
DOW   29,590.41
QQQ   275.51
Get 1TB of Top-Rated Cloud Storage for Life for Just $112
Cash Holders STILL Aren’t Taking Steps to Prepare (Ad)pixel
Saudi Arabia's triumphant week reclaims the West's embrace
Poverty, inflation, fear: Egypt's economy pushed to brink
Sell every Stock except ONE (Ad)
Labour conference starts with focus on 'immoral' tax cuts
German leader continues Gulf tour with stops in UAE, Qatar
Sell every Stock except ONE (Ad)
Germany secures more gas shipments as Scholz visits Gulf
Poverty and inflation: Egypt's economy hit by global turmoil
S&P 500   3,693.23
DOW   29,590.41
QQQ   275.51
Get 1TB of Top-Rated Cloud Storage for Life for Just $112
Cash Holders STILL Aren’t Taking Steps to Prepare (Ad)pixel
Saudi Arabia's triumphant week reclaims the West's embrace
Poverty, inflation, fear: Egypt's economy pushed to brink
Sell every Stock except ONE (Ad)
Labour conference starts with focus on 'immoral' tax cuts
German leader continues Gulf tour with stops in UAE, Qatar
Sell every Stock except ONE (Ad)
Germany secures more gas shipments as Scholz visits Gulf
Poverty and inflation: Egypt's economy hit by global turmoil
NASDAQ:ATXI

Avenue Therapeutics - ATXI Short Interest Ratio & Short Volume

$4.50
-2.10 (-31.82%)
(As of 09/23/2022 12:00 AM ET)
Add
Compare
Today's Range
$3.62
$6.35
50-Day Range
$3.21
$67.50
52-Week Range
$3.00
$27.75
Volume
5.70 million shs
Average Volume
426,972 shs
Market Capitalization
$6.62 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

Avenue Therapeutics Short Interest Data

Current Short Volume
151,200 shares
Previous Short Volume
79,000 shares
Change Vs. Previous Month
+91.39%
Dollar Volume Sold Short
$36,408.96
Short Interest Ratio / Days to Cover
0.5
Last Record Date
August 31, 2022
Outstanding Shares
1,470,000 shares
Float Size
11,330,000 shares
Short Percent of Float
1.33%
Today's Trading Volume
5,699,441 shares
Average Trading Volume
426,972 shares
Today's Volume Vs. Average
1,234.85%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Avenue Therapeutics ?

Sign up to receive the latest short interest report for Avenue Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

ATXI Short Interest Over Time

ATXI Days to Cover Over Time

ATXI Percentage of Float Shorted Over Time



Avenue Therapeutics (NASDAQ:ATXI) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
8/31/2022151,200 shares $36,408.96 +91.4%1.3%0.5 $0.24
8/15/202279,000 shares $23,091.70 +28.5%0.7%0.3 $0.29
7/31/202261,500 shares $15,768.60 +104.3%0.5%0.2 $0.26
7/15/202230,100 shares $8,033.69 -61.2%0.3%0.1 $0.27
6/30/202277,600 shares $20,897.68 -17.5%0.7%0.2 $0.27
6/15/202294,000 shares $25,192.00 +50.9%0.8%0.3 $0.27
5/31/202262,300 shares $17,444.00 -31.9%0.6%0.1 $0.28
5/15/202291,500 shares $30,927.00 +10.5%0.8%0 $0.34
4/30/202282,800 shares $30,611.16 +212.5%0.8%0 $0.37
4/15/202226,500 shares $12,725.30 +108.7%0.2%0 $0.48
3/31/202212,700 shares $6,115.05 -98.1%0.1%0 $0.48
3/15/2022674,600 shares $467,497.80 +177.6%6.7%0.1 $0.69
2/28/2022243,000 shares $82,595.70 +2.3%2.4%0.1 $0.34
2/15/2022237,600 shares $144,936.00 -43.0%2.4%0.4 $0.61
1/31/2022416,900 shares $304,753.90 -15.0%4.1%0.8 $0.73
1/15/2022490,300 shares $431,464.00 -3.0%5.4%1 $0.88
12/31/2021505,600 shares $459,084.80 -23.7%6.2%1 $0.91
12/15/2021662,500 shares $602,875.00 +515.7%8.1%1.4 $0.91
11/30/2021107,600 shares $151,716.00 -20.2%1.2%0.3 $1.41
11/15/2021134,800 shares $184,676.00 -50.2%1.8%1.3 $1.37
10/29/2021270,500 shares $427,390.00 +21.1%4.1%4.2 $1.58
10/15/2021223,300 shares $283,591.00 -10.8%3.4%3.4 $1.27
9/30/2021250,200 shares $372,798.00 -10.1%3.8%3 $1.49
9/15/2021278,400 shares $462,144.00 -1.7%4.2%2 $1.66
8/31/2021283,300 shares $512,773.00 +6.7%4.3%1 $1.81
8/13/2021265,400 shares $453,834.00 -13.8%4.0%0.9 $1.71
7/30/2021308,000 shares $551,320.00 -27.0%4.7%1 $1.79
7/15/2021421,800 shares $873,126.00 +17.8%6.4%1.3 $2.07
6/30/2021358,100 shares $898,831.00 -28.0%5.4%0.9 $2.51
6/15/2021497,000 shares $1.39 million -4.5%7.5%1.2 $2.80
5/28/2021520,500 shares $2.58 million -2.3%7.9%1.8 $4.96
5/14/2021532,500 shares $2.22 million -13.8%8.0%1.6 $4.16
4/30/2021617,400 shares $3.24 million 0.0%9.3%1.8 $5.24
4/15/2021617,500 shares $2.95 million +37.6%9.3%2 $4.77
3/31/2021448,700 shares $2.58 million +11.5%6.8%1.8 $5.75
3/15/2021402,500 shares $2.75 million +12.8%6.1%1.5 $6.84
2/26/2021357,000 shares $1.76 million -6.9%5.4%0.9 $4.94
2/12/2021383,600 shares $2.62 million -17.9%5.8%1 $6.83
1/29/2021467,000 shares $2.81 million -11.2%7.0%1.2 $6.01
1/15/2021526,000 shares $3.31 million -12.4%7.9%1.4 $6.30
12/31/2020600,600 shares $3.48 million +73.7%9.0%1.1 $5.80
12/15/2020345,800 shares $1.25 million +13.0%5.2%0.6 $3.62
11/30/2020306,100 shares $1.04 million -7.2%4.6%1 $3.41
11/15/2020329,900 shares $1.09 million +9.8%5.0%1.2 $3.29
10/30/2020300,500 shares $955,590.00 +4.1%4.5%1.1 $3.18
10/15/2020288,800 shares $1.15 million +110.7%4.4%1.2 $3.98
9/30/2020137,100 shares $1.48 million -8.1%2.1%3 $10.83
9/15/2020149,200 shares $1.78 million +0.8%2.3%2.9 $11.96
8/31/2020148,000 shares $1.65 million -13.7%2.2%3.1 $11.13
8/14/2020171,400 shares $1.82 million -34.4%2.6%3.2 $10.59













ATXI Short Interest - Frequently Asked Questions

What is Avenue Therapeutics' current short interest?

Short interest is the volume of Avenue Therapeutics shares that have been sold short but have not yet been closed out or covered. As of August 31st, traders have sold 151,200 shares of ATXI short. 1.33% of Avenue Therapeutics' shares are currently sold short. Learn More on Avenue Therapeutics' current short interest.

What is a good short interest percentage for Avenue Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.33% of Avenue Therapeutics' floating shares are currently sold short.

Is Avenue Therapeutics' short interest increasing or decreasing?

Avenue Therapeutics saw a increase in short interest during the month of August. As of August 31st, there was short interest totaling 151,200 shares, an increase of 91.4% from the previous total of 79,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Avenue Therapeutics' float size?

Avenue Therapeutics currently has issued a total of 21,990,000 shares. Some of Avenue Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Avenue Therapeutics currently has a public float of 11,330,000 shares.

How does Avenue Therapeutics' short interest compare to its competitors?

1.33% of Avenue Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Avenue Therapeutics: Altamira Therapeutics Ltd. (3.52%), InMed Pharmaceuticals Inc. (0.11%), Tenax Therapeutics, Inc. (5.68%), Panbela Therapeutics, Inc. (0.67%), Aditxt, Inc. (180.86%), Sonnet BioTherapeutics Holdings, Inc. (8.41%), Histogen Inc. (4.48%), Dermata Therapeutics, Inc. (1.56%), Statera Biopharma, Inc. (2.73%), and Kiora Pharmaceuticals, Inc. (45.56%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Occidental Petroleum Co. ($4.91 billion), Charter Communications, Inc. ($3.53 billion), Suncor Energy Inc. ($2.26 billion), T. Rowe Price Group, Inc. ($2.01 billion), Chesapeake Energy Co. ($1.92 billion), Lucid Group, Inc. ($1.84 billion), Plug Power Inc. ($1.81 billion), Williams-Sonoma, Inc. ($1.66 billion), Coinbase Global, Inc. ($1.64 billion), and Lumen Technologies, Inc. ($1.50 billion). View all of the most shorted stocks.

What does it mean to sell short Avenue Therapeutics stock?

Short selling ATXI is an investing strategy that aims to generate trading profit from Avenue Therapeutics as its price is falling. ATXI shares are trading down $2.10 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Avenue Therapeutics?

A short squeeze for Avenue Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ATXI, which in turn drives the price of the stock up even further.

How often is Avenue Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ATXI, twice per month. The most recent reporting period available is August, 31 2022.



This page (NASDAQ:ATXI) was last updated on 9/25/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.